CUSIP
No. 17248W105 |
|
1. |
Names
of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only): |
|
|
Peter
J. Werth |
|
2. |
Check
the Appropriate Box if a Member of a Group |
(a)
☐ |
|
|
(b)
☐ |
3. |
SEC
Use Only |
|
4. |
Source
of Funds (See Instructions): PF |
|
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): |
|
|
☐ |
|
6. |
Citizenship
or Place of Organization: United States |
|
|
Number
of |
7.
Sole Voting Power: |
21,849*
|
|
Shares
Beneficially |
8.
Shared Voting Power: |
985,711*
|
|
Owned
by |
|
|
|
Each
Reporting |
9.
Sole Dispositive Power: |
21,849* |
|
Person
With |
10.
Shared Dispositive Power: |
985,711*
|
11. |
Aggregate
Amount Beneficially Owned by Each Reporting Person: |
|
1,007,560* |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): |
|
☐ |
13. |
Percent
of Class Represented by Amount in Row (11): 8.9%* |
14. |
Type
of Reporting Person (See Instructions): IN |
*As
of the date hereof, Peter J. Werth (“Mr. Werth”) may be deemed to beneficially own an aggregate of 985,711 shares
of common stock, par value $0.0001 per share (the “Common Stock”), of Cingulate Inc. (the
“Issuer”) consisting of (i) 21,849 shares of Common Stock and stock options to purchase 2,246 shares of Common
Stock held directly by Mr. Werth and (ii) 975,165 shares of Common Stock and warrants to purchase up to 8,300 shares of Common Stock
held directly by Werth Family Investment Associates LLC where Mr. Werth serves as the Chief Executive Officer and Manager. Excludes
15,737 shares of Common Stock underlying unvested stock options held directly by Mr. Werth. As a result of the foregoing, for purposes of
Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Werth may be deemed to beneficially own 1,007,560 shares of
Common Stock, representing 8.9% of the Common Stock of the Issuer deemed issued and outstanding as of the date hereof.
The
foregoing reported beneficial ownership percentage is based upon 11,309,412 shares of Common Stock issued and outstanding as of September 30, 2022, based on information reported by the
Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.
CUSIP
No. 17248W105 |
|
1. |
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only): |
|
|
Werth Family Investment |
|
2. |
Check the Appropriate Box if a Member of a Group |
(a)
☐ |
|
|
(b)
☐ |
3. |
SEC
Use Only |
|
4. |
Source
of Funds (See Instructions): WC |
|
5. |
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e): |
|
|
☐ |
|
6. |
Citizenship
or Place of Organization: Connecticut |
|
|
Number
of |
7.
Sole Voting Power: |
0 |
|
Shares
Beneficially |
8.
Shared Voting Power: |
983,465** |
|
Owned
by |
|
|
|
Each
Reporting |
9.
Sole Dispositive Power: |
0 |
|
Person
With |
10.
Shared Dispositive Power: |
983,465** |
11. |
Aggregate
Amount Beneficially Owned by Each Reporting Person: |
|
983,465** |
12. |
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions): |
|
☐ |
13. |
Percent
of Class Represented by Amount in Row (11): 8.7%** |
14. |
Type
of Reporting Person (See Instructions): OO |
**As
of the date hereof, Werth Family Investment Associates LLC (“Werth Associates”) may be deemed to beneficially own
983,465 shares of common stock, par value $0.0001 per share (the “Common Stock”), of Cingulate Inc. (the “Issuer”),
consisting of 975,165 shares of Common Stock and warrants to purchase up to 8,300 shares of Common Stock. As a result of the foregoing,
for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Werth may be deemed to beneficially own 983,465
shares of Common Stock, representing 8.7% of the Common Stock of the Issuer deemed issued and outstanding as of the date hereof.
The
foregoing reported beneficial ownership percentage is based upon 11,309,412 shares of Common Stock issued and outstanding as of September 30, 2022, based on information reported by the
Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.
Explanatory
Note
This
Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D field on behalf of the Reporting Persons
with the Securties and Exchange Commission on December 20, 2021 (the “Schedule 13D”). Except as specifically provided
herein, this Amendment does not modify or amend any of the information previously reported in the Schedule 13D. Capitalized terms used
and not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to
each item shall be deemed incorporated by reference in all other items, as applicable.
Item
3. Source and Amount of Funds or Other Consideration.
On
December 10, 2021 (the “Event Date”), the Issuer closed an underwritten public offering (the “IPO”)
of 4,166,666 Units (the “Units”) and warrants to purchase 624,999 shares of Common Stock, with each Unit consisting
of one share of Common Stock and one warrant to purchase one share of Common Stock.
Prior
to the IPO, Mr. Werth beneficially owned 858,280 shares of Common Stock consisting of (i) 21,849 shares of Common Stock held directly
by Mr. Werth and (ii) 836,431 shares of Common Stock held directly by Werth Associates.
On
December 7, 2021, in connection with the IPO, the Issuer granted Mr. Werth an option to purchase 8,983 shares of Common Stock for no
consideration (the “Option”). The Option vests in four (4) equal annual installments commencing on December 7, 2022.
The exercise price of the Option is $6.00 per share and the Option expires on December 7, 2031.
On
the Event Date, Werth Associates purchased 8,300 Units in the IPO at a price of $6.00 per Unit for an aggregate purchase price of $49,800.
The warrants comprising the Units are exercisable at $6.00 per share and expire December 10, 2026. Werth Associates purchased the Units
with investment capital.
On
February 25, 2022, the Issuer granted Mr. Werth a stock option to purchase 9,000 shares of Common Stock for no consideration. The stock
option vests on the one-year anniversary of the date of grant. The exercise price of the stock option is $1.38 per share and the stock
option expires on February 25, 2032.
On
March 17, 2022, Werth Associates purchased 27,000 shares of Common Stock at $1.79 per share for an aggregate purchase price of $48,330.
Werth Associates purchased the Common Stock with investment capital.
On
September 6, 2022, Werth Associates purchased 74,500 shares of Common Stock at $1.5198 per share for an aggregate purchase price of $113,225.
Werth Associates purchased the Common Stock with investment capital.
On
December 13, 2022, Werth Associates purchased 28,934 shares of Common Stock at a weigted average price of $0.9823 per share for an aggregate
purchase price of $28,422. Werth Associates purchased the Common Stock with investment capital.
Item
5. Interest in Securities of the Issuer.
The
information contained in rows 7, 8, 9, 10, 11 and 13 of the cover page of this Schedule 13D and the information set forth in or incorporated
by reference in Item 2, Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5.
The
aggregate percentage of Common Stock reported owned by the Reporting Persons is based upon 11,309,412 shares of Common Stock outstanding,
which is the total number of shares of Common Stock outstanding as of September 30, 2022, as reported in the Issuer’s Quarterly
Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.
As
of the date hereof, Mr. Werth may be deemed to beneficially own 1,007,560 shares of Common Stock of the Issuer, consisting of (i) 21,849
shares of Common Stock and stock options to purchase 2,246 shares of Common Stock held directly by Mr. Werth and (ii) 975,165 shares
of Common Stock and warrants to purchase up to 8,300 shares of Common Stock held directly by Werth Associates. As a result of the foregoing,
and for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Mr. Werth may be deemed to beneficially own 1,007,560
shares of Common Stock, representing 8.9% of the Common Stock of the Issuer deemed issued and outstanding as of the date hereof.
Except
as described herein, during the past sixty (60) days on or prior to the date hereof, there were no other purchases or sales of shares
of Common Stock, or securities convertible into or exchangeable for shares of Common Stock, by the Reporting Persons or any person or
entity for which the Reporting Persons possess voting or dispositive control over the securities thereof.
Signature
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
|
By: |
/s/
Peter J. Werth* |
|
|
Peter
J. Werth |
|
WERTH FAMILY INVESTMENT ASSOCIATES LLC |
|
|
|
|
By: |
Peter J. Werth, its Chief Executive Officer |
|
By: |
/s/
Peter J. Werth |
|
Name:
|
Peter
J. Werth |
|
Title: |
Chief
Executive Officer |
*
This reporting person disclaims beneficial ownership of these reported securities except to the extent of its pecuniary interest therein,
and this report shall not be deemed an admission that any such person is the beneficial owner of these securities for purposes of Section
16 of the U.S. Securities Exchange Act of 1934, as amended, or for any other purpose.
Attention:
Intentional misstatements or omissions of fact constitute
Federal criminal violations (see 18 U.S.C. 1001).